To further improve therapy quality, increase convenience and drive patient engagement in managing their health, the firms intend to advance chronic care management using connected therapy.

Roche Professional Diagnostics point of care senior vice-president Jeremy Moss said: "By combining Qualcomm Life’s leadership in powering connected health solutions with our point-of-care expertise, we are taking an important step forward to realize our connected care strategy; ultimately enabling physicians to improve the overall quality of life for patients."

Under the deal, Roche will use Qualcomm’s 2net platform to seamlessly and securely capture data from a patient’s medical devices, starting with anticoagulation meters. This data will be transferred to Roche’s cloud-based back-end services.

The 2net Platform is a secure wireless solution, which offers simple and efficient way to exchange relevant health information between chronic disease patients and their care team or clinic, and enable reduced therapy complications and total cost of care.

Qualcomm Life senior vice-president and general manager Rick Valencia said: "We are thrilled to be working with a global industry leader in diagnostics and excited by the positive impact our collaboration with Roche can have on patient empowerment at the point-of-care."

Image: The administration and R&D buildings, Roche Diagnostics Ltd, Rotkreuz. Photo: courtesy of F. Hoffmann-La Roche Ltd.